- Djaelani YA, Giese T, Sommerer C, Czock D. Pharmacodynamic Monitoring of Ciclosporin and Tacrolimus: Insights From Nuclear Factor of Activated T-Cell-Regulated Gene Expression in Healthy Volunteers. Ther Drug Monit 2023;45:87-94.
- Huppertz A, Bollmann J, Behnisch R, Bruckner T, Zorn M, Burhenne J, Haefeli WE, Czock D. Differential Effect of a Continental Breakfast on Tacrolimus Formulations With Different Release Characteristics. Clin Pharmacol Drug Dev 2021;10:899-907.
- Huppertz A, Ott C, Bruckner T, Foerster KI, Burhenne J, Weiss J, Zorn M, Haefeli WE, Czock D. Prolonged-Release Tacrolimus Is Less Susceptible to Interaction With the Strong CYP3A Inhibitor Voriconazole in Healthy Volunteers. Clin Pharmacol Ther 2019;106:1290-1298.
- Economou CJP, Kielstein JT, Czock D, Xie J, Field J, Richards B, Tallott M, Visser A, Koenig C, Hafer C, Schmidt JJ, Lipman J, Roberts JA. Population pharmacokinetics of vancomycin in critically ill patients receiving prolonged intermittent renal replacement therapy. Int J Antimicrob Agents 2018;52:151-157.
- Czock D, Spitaletta M, Keller F. Suboptimal antimicrobial drug exposure in patients with renal impairment. Int J Clin Pharm 2015;37:906-16.
- Czock D, Keller F, Seidling HM. Pharmacokinetic predictions for patients with renal impairment: focus on peptides and protein drugs. Br J Clin Pharmacol 2012;74:66-74.
- Hafner V, Czock D, Burhenne J, Riedel KD, Bommer J, Mikus G, Machleidt C, Weinreich T, Haefeli WE. Pharmacokinetics of sulfobutylether-beta-cyclodextrin and voriconazole in patients with end-stage renal failure during treatment with two hemodialysis systems and hemodiafiltration. Antimicrob Agents Chemother 2010;54:2596-602.
- Czock D, Keller F, Hameister J, Tiefenbach B, Mitzner S. Levomethadone is poorly removed by the molecular adsorbents recirculating system. J Clin Psychopharmacol 2009;29:622-4.
- Czock D, Rasche FM, Boesler B, Shipkova M, Keller F. Irinotecan in cancer patients with end-stage renal failure. Ann Pharmacother 2009;43:363-9.
- Czock D, Bertsche T, Haefeli WE. Drug dose adjustments in patients with renal impairment. Am J Kidney Dis 2009;54:983-4; author reply 985-6.
